Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-008234
Filing Date
2014-11-14
Accepted
2014-11-14 16:04:24
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0914_immudyneinc.htm 10-Q 320939
2 CERTIFICATION f10q0914ex31i_immudyneinc.htm EX-31.1 9959
3 CERTIFICATION f10q0914ex32i_immudyneinc.htm EX-32.1 2753
  Complete submission text file 0001213900-14-008234.txt   2950122

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE immd-20140930.xml EX-101.INS 365231
5 XBRL SCHEMA FILE immd-20140930.xsd EX-101.SCH 30546
6 XBRL CALCULATION FILE immd-20140930_cal.xml EX-101.CAL 27980
7 XBRL DEFINITION FILE immd-20140930_def.xml EX-101.DEF 101970
8 XBRL LABEL FILE immd-20140930_lab.xml EX-101.LAB 252169
9 XBRL PRESENTATION FILE immd-20140930_pre.xml EX-101.PRE 189300
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 141223972
SIC: 2833 Medicinal Chemicals & Botanical Products